THY1 and glioma: Experiments conducted by Zhang et al. indeed confirm that the CD90− subpopulation mainly boost glioma cell proliferation, migration, and adhesion, whereas the CD90+ subpopulation primarily facilitates neoangiogenesis via pericyte differentiation and interaction with endothelial cells [168].